[1]
A. . Dutta, T. . Satapathy, and P. Sahu, “EXPLOITING RECEPTOR NANOCLUSTERS TO BIAS CLATHRIN VS. CAVEOLIN UPTAKE: MOLECULAR DESIGN RULES FOR TARGETED ANTI-CANCER NANOMEDICINES”, J. Appl. Pharmco. Toxicol., vol. 2, no. 1, pp. 17–49, Jun. 2026.